[来自Stephania hernandifolia的两种新型原柏类化物]
Wei-Hua Dai1, Xin-Tao Cui1, Yu-Jiao Tu1
1School of Chemistry and Chemical Engineering, Kunming University Kunming 650214, China.
概括
从Stephania hernandifolia中分离出四种类化合物,以及两种新的原贝林类化合物. 化合物N-转基因氨酸和N-cis-氨酸氨酸抑制了α-葡萄糖酶.
科学领域:
- 植物化学 植物化学
- 自然产品化学 自然产品化学
- 药物鉴定学是指药物鉴定学.
相关概念视频
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.2K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.2K
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K


